Đang chuẩn bị liên kết để tải về tài liệu:
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: Study protocol of the target selection phase III CHIC-STS trial

Xuân Thu 82 8 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

The value of chemotherapy in soft tissue sarcoma (STS) remains controversial. Several expert teams consider that chemotherapy provides a survival advantage and should be proposed in high-risk (HR) patients. However, the lack of accuracy in identifying HR patients with conventional risk factors (large, deep, FNCLCC grade 3, extremity STS) is an issue that cannot be neglected. |

TÀI LIỆU LIÊN QUAN

Ebook Value-based Marketing: Marketing Strategies for Corporate Growth and Shareholder Value - Peter Doyle

Product redesigning, cost reduction, component substitution, and their influence in value management in micro and small enterprises

Employer attractiveness: Measurement scale development and validation

Valuation Measuring and Managing the Value of Companies

Bài giảng Chapter 2: Time Value of Money

Lecture Chapter 5: Introduction to Valuation: The Time Value of Money

Vietnam tea industry: An analysis from value chain approach

Lecture Managerial finance - Chapter 2: Time value of money

Solving a nonlinear biharmonic boundary value problem

Evaluating total operational value and associated risks of financial holding companies in Taiwan

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.